Adrixetinib is a tyrosine kinase inhibitor with potential use as an antineoplastic agent.
For research use only. We do not sell to patients.
Name | Adrixetinib ( Q-702 ) |
---|---|
Iupac Chemical Name | N-{5-[(6,7-dimethoxyquinolin-4-yl)oxy]pyridin-2-yl}-1- propyl-4-(2,2,2-trifluoroethoxy)-1H-pyrazole-3- carboxamide |
Synonyms | Q-702 ; Adrixetinib ; |
Molecular Formula | C25H24F3N5O5 |
Molecular Weight | 531.48 |
Smile | O=C(C1=NN(CCC)C=C1OCC(F)(F)F)NC2=NC=C(OC3=CC=NC4=CC(OC)=C(OC)C=C34)C=C2 |
InChiKey | BWUUJXXFCSYLFW-UHFFFAOYSA-N |
InChi | InChI=1S/C25H24F3N5O5/c1-4-9-33-13-21(37-14-25(26,27)28)23(32-33)24(34)31-22-6-5-15(12-30-22)38-18-7-8-29-17-11-20(36-3)19(35-2)10-16(17)18/h5-8,10-13H,4,9,14H2,1-3H3,(H,30,31,34) |
CAS Number | 2394874-66-7 |
Related CAS | 2991273-39-1 (HCl salt) |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Solid powder |
---|---|
Purity | 98% Min. |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |